Resveratrol regulates the silent information regulator 1–nuclear factor‐κB signaling pathway in intrahepatic cholestasis of pregnancy

Abstract

These data indicate that resveratrol might protect syncytiotrophoblast against TCA-induced inflammatory injury by upregulation of SIRT1 and downregulation of NF-κB and TNF-α. Resveratrol could be a potential therapeutic target for ICP.